Lineage Cell Therapeutics Inc Tangible Net Worth Ratio
Lineage Cell Therapeutics Inc tangible net worth ratio. Lineage Cell Therapeutics Inc (LCTX) has a Tangible Net Worth Ratio of -52.4% as of September 2025. This metric is calculated by deducting intangible assets ($31.70 Million) from net assets ($20.80 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check Lineage Cell Therapeutics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Lineage Cell Therapeutics Inc (1991–2024)
Tangible net worth ratio of Lineage Cell Therapeutics Inc from 1991 to 2024. This chart shows how Lineage Cell Therapeutics Inc's Tangible Net Worth Ratio has changed across 27 annual periods from 1991 to 2024. As of September 2025, the ratio stands at -52.4%, reflecting net assets of $20.80 Million with intangible assets of $31.70 Million USD. See how liquid is Lineage Cell Therapeutics Inc's working capital to evaluate short-term liquidity relative to the company's equity base.
Lineage Cell Therapeutics Inc Tangible Net Worth Ratio by Year (1991–2024)
Lineage Cell Therapeutics Inc tangible net worth ratio by year from 1991 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Lineage Cell Therapeutics Inc from 1991 to 2024, covering 27 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see Lineage Cell Therapeutics Inc market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 39.6% | $77.01 Million | $46.54 Million | $113.22 Million | ▲ +14.6 pp |
| 2023 | 24.9% | $62.02 Million | $46.56 Million | $101.02 Million | ▼ -10.2 pp |
| 2022 | 35.1% | $71.94 Million | $46.69 Million | $123.66 Million | ▼ -13.4 pp |
| 2021 | 48.5% | $90.90 Million | $46.82 Million | $174.54 Million | ▼ -2.1 pp |
| 2020 | 50.6% | $95.13 Million | $47.03 Million | $107.95 Million | ▼ -6.1 pp |
| 2019 | 56.6% | $111.25 Million | $48.25 Million | $125.48 Million | ▼ -40.0 pp |
| 2018 | 96.6% | $92.25 Million | $3.12 Million | $101.66 Million | ▲ +0.8 pp |
| 2017 | 95.8% | $164.26 Million | $6.90 Million | $173.24 Million | ▲ +3.6 pp |
| 2016 | 92.2% | $130.51 Million | $10.21 Million | $142.57 Million | ▲ +36.1 pp |
| 2015 | 56.1% | $76.45 Million | $33.59 Million | $94.66 Million | ▲ +18.0 pp |
| 2014 | 38.1% | $62.72 Million | $38.85 Million | $74.90 Million | ▲ +47.4 pp |
| 2013 | -9.3% | $42.26 Million | $46.21 Million | $57.73 Million | ▼ -25.0 pp |
| 2012 | 15.7% | $24.29 Million | $20.49 Million | $29.75 Million | ▼ -39.4 pp |
| 2011 | 55.1% | $41.46 Million | $18.62 Million | $45.83 Million | ▼ -13.8 pp |
| 2010 | 68.9% | $49.43 Million | $15.39 Million | $53.27 Million | ▼ -31.1 pp |
| 2009 | 100.0% | $11.05 Million | $0.00 | $13.43 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $344.77K | $0.00 | $1.52 Million | ▲ +0.0 pp |
| 2000 | 100.0% | $1.32 Million | $0.00 | $1.68 Million | ▲ +0.0 pp |
| 1999 | 100.0% | $5.08 Million | $0.00 | $5.68 Million | ▲ +0.0 pp |
| 1998 | 100.0% | $2.40 Million | $0.00 | $2.80 Million | ▲ +0.0 pp |
| 1997 | 100.0% | $6.50 Million | $0.00 | $8.30 Million | ▲ +0.0 pp |
| 1996 | 100.0% | $2.80 Million | $0.00 | $3.00 Million | ▲ +0.0 pp |
| 1995 | 100.0% | $2.80 Million | $0.00 | $3.00 Million | ▲ +0.0 pp |
| 1994 | 100.0% | $3.20 Million | $0.00 | $3.60 Million | ▲ +0.0 pp |
| 1993 | 100.0% | $5.80 Million | $0.00 | $5.90 Million | ▲ +0.0 pp |
| 1992 | 100.0% | $3.40 Million | $0.00 | $3.50 Million | ▲ +0.0 pp |
| 1991 | 100.0% | $4.60 Million | $0.00 | $4.80 Million | — |